Alector Inc (ALEC NASDAQ) stock market data APIs
$2.2338
-0.01(-0.4%)
as of March 17, 2026
Try our APIs with
free plan!
Alector Inc Financial Data Overview
Price chart is built with
Anychart
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
Prev. Close
2.2338
Open
2.2202
High
2.2615
Low
2.183
52 wk Range
0.87-3.3999
Market Cap
246 M
Shares Outstanding
110 M
Revenue
21 045 K
EPS
-0.34
Beta
0.547
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Alector Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Alector Inc data using free add-ons & libraries
Get Alector Inc Fundamental Data
Alector Inc Fundamental data includes:
- Net Revenue: 21 045 K
- EBITDA: -147 367 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.3913
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alector Inc News
New
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles
Quick Read Hims & Hers (HIMS) jumped 34.47% past week to $22.16, targets $23-$28. Teladoc Health (TDOC) at $5.30, Deutsche Bank target $11. Alector (ALEC) up 40.38% YTD to $2.19, BTIG target $6. Anal...
Global Market Stocks With Estimated Value Opportunities In February 2026
As global markets navigate a complex landscape marked by the Federal Reserve's steady interest rates and fluctuating consumer confidence, investors are keenly observing sectors where value stocks have...
Looking At The Narrative For Alector (ALEC) After Latozinemab Setback And Cost Cuts
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Alector has shifted slightly, moving from 2.05 to 2...
Global Market Insights On 3 Stocks That Might Be Priced Below Intrinsic Value
As global markets navigate a landscape marked by interest rate adjustments and mixed economic signals, investors are keenly observing shifts in stock valuations. In this context, identifying stocks th...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
